The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Dahms Bradford D. since 2021.
This trader's CIK number is 1787307.
At the time of last reporting, Dahms Bradford D. was the Chief Financial Officer of Theseus Pharmaceuticals, Inc.. (stock ticker symbol THRX).
Also see all insider trading activities at Theseus Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | THRX | 1,970 | $19,999 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-12-21 | THRX | Buy | 1,970 | 10.15 | 19,999 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Dahms Bradford D. (Chief Financial Officer of Theseus Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.